A patient’s refusal of an AI scribe has led to a cancelled doctor’s visit, with a regulator backing clinical discretion over patient consent.

Alternative protein innovator V2food has penned new deals as research projects a growing global market for meat substitutes.

Inside Lovisa’s low-cost, high-efficiency model that’s quietly delivering 14x returns and global dominance in the fast jewellery game.